Survey sponsor: Stephanie Hooker, PhD, MPH, Principal Investigator
Funder: National Heart, Lung and Blood Institute
Description: The Long-term Effectiveness of the Anti-obesity Medication Phentermine (LEAP) study is a research study funded by the National Institutes of Health. In this research study, we are testing whether the medication called phentermine is an effective and safe long-term treatment for obesity. This medicine has been used for many years to help people manage their weight by controlling appetite. This medication has been approved for short-term use (up to 12 weeks at a time). However, many obesity medicine providers have recommended longer term use, just like taking a medication for other diseases like high blood pressure or diabetes. LEAP will test whether phentermine is a safe and effective way to lose weight when taking it for up to 2 years.
The Principal Investigator at HealthPartners for the LEAP study is Dr. Stephanie Hooker. She can be reached at Stephanie.A.Hooker@HealthPartners.Com or 952-967-5056.
If you would like to see if you are eligible to participate, click here.
If you received a survey invitation and would like to participate, please contact the Center for Evaluation and Survey Research:
(952) 967-5999
LEAPStudy@healthpartners.com
